Insider Transactions in Q4 2025 at Aclaris Therapeutics, Inc. (ACRS)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2025
|
James Loerop Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,994
-19.2%
|
$101,982
$3.01 P/Share
|
|
Dec 31
2025
|
James Loerop Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
73,750
+29.41%
|
-
|
|
Dec 31
2025
|
Kevin Balthaser Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,934
-11.98%
|
$59,802
$3.01 P/Share
|
|
Dec 31
2025
|
Kevin Balthaser Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
73,750
+30.72%
|
-
|
|
Dec 02
2025
|
Hugh M. Davis President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,750
+50.0%
|
-
|